NCT05965999View on ClinicalTrials.gov

Lucid Registry Study

UnknownOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

April 11, 2023

Primary Completion Date

June 1, 2024

Study Completion Date

June 1, 2024

Conditions
Barrett EsophagusEsophageal AdenocarcinomaBarretts Esophagus With DysplasiaBarrett's Esophagus Without Dysplasia
Interventions
DEVICE

EsoCheck

EsoCheck® (EC) is an FDA 510(k) cleared device that is indicated for use in the collection and retrieval of surface cells of the esophagus in the general population 12 years of age and older.

Trial Locations (1)

92630

RECRUITING

LUCID DX, Lake Forest

Sponsors
All Listed Sponsors
lead

Lucid Diagnostics, Inc.

INDUSTRY